The 2014-2015 Ebola outbreak in West Africa shocked the world with its devastation and its rapid migration to multiple continents. As the systems meant to respond to this sort of epidemic failed, the disease exposed not just weaknesses in international infectious disease surveillance and management, but the failures of governments, humanitarian organizations, and international institutions to handle the legal, ethical, and economic questions that arose with an event of this scale. GLOBAL MANAGEMENT OF INFECTIOUS DISEASE AFTER EBOLA unites the insights of Ebola's first responders with those the world's foremost experts in law, economics, vaccine development, and global migration to identify missed opportunities from the Ebola crisis -- and to apply these lessons to emerging infectious disease threats. Framed with critical discussions of both the global health financing infrastructures that precipitated the response and the ethical and human rights dilemmas that resulted from it, this volume is much more than postmortem to an outbreak: it is a vital, sometimes damning examination of where we've been and where we're going in the face of emerging infectious diseases.

Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond the three hardest-hit countries and beyond the health sector. Education, child protection, commerce, transportation, and human rights have all suffered. The consequences and lethality of Ebola have increased interest in coordinated global response to infectious threats, many of which could disrupt global health and commerce far more than the recent outbreak. In order to explore the potential for improving international management and response to outbreaks the National Academy of Medicine agreed to manage an international, independent, evidence-based, authoritative, multistakeholder expert commission. As part of this effort, the Institute of Medicine convened four workshops in summer of 2015. This commission report considers the evidence supplied by these workshops and offers conclusions and actionable recommendations to guide policy makers, international funders, civil society organizations, and the private sector.

The most recent Ebola epidemic that began in late 2013 alerted the entire world to the gaps in infectious disease emergency preparedness and response. The regional outbreak that progressed to a significant public health emergency of international concern (PHEIC) in a matter of months killed 11,310 and infected more than 28,616. While this outbreak bears some unique distinctions to past outbreaks, many characteristics remain the same and contributed to tragic loss of human life and unnecessary expenditure of capital: insufficient knowledge of the disease, its reservoirs, and its transmission; delayed prevention efforts and treatment; poor control of the disease in hospital settings; and inadequate community and international responses. Recognizing the opportunity to learn from the countless lessons of this epidemic, the National Academies of Sciences, Engineering, and Medicine convened a workshop in March 2015 to discuss the challenges to successful outbreak responses at the scientific, clinical, and global health levels. Workshop participants explored the epidemic from multiple perspectives, identified important questions about Ebola that remained unanswered, and sought to apply this understanding to the broad challenges posed by Ebola and other emerging pathogens, to prevent the international community from being taken by surprise once again in the face of these threats. This publication summarizes the presentations and discussions from the workshop.

This unique guidebook and reference will enable physicians to develop an informed differential diagnosis of patients who have lived or traveled in other countries or who have had exposures that could lead to infections with unusual or unfamiliar pathogens. It draws together information from many diverse sources in an accessible format that will foster a logical clinical method. The first section of the book outlines a systematic approach to the patient's history, analyzing factors that affect probability of infection, with an evaluation of clinical findings. The second section presents a profile of infectious diseases for every major geographic area of the world, giving supplemental information for each country discussed. The third part describes key features, including epidemiology, clinicopathologic findings, diagnosis, and management of 235 infections. Valuable appendix materials define important terms and give practical information on incubation periods, vectors, transmission via blood transfusion and pathogens in foods.

Now in full color, the #1 text spanning the fields of public health and preventive medicine brings you fully up to date on the issues and topics you need to know A Doody's Core Title for 2023! Maxcy-Rosenau-Last Public Health and Preventive Medicine has been updated and revised for the first time in more than a decade. This highly anticipated and extensive edition provides the most current information and insights available on evidence-based public health and preventive medicine, from basic methodologies of public health to principles of epidemiology and infection control to environmental toxicology to global health. The most comprehensive resource of its kind, Maxcy-Rosenau-Last Public Health and Preventive Medicine is the clear choice for anyone seeking a career in public health. Features: • Edited and written by a who's who of global experts • 384 photos and illustrations • New full-color format and improved artwork • Significantly expanded coverage of diseases and preventive methods common in international markets • Greater use of tables and summary lists for easier reading and retention